RESEARCH, MENTORSHIP AND THE PHD EXPERIENCE Supervisor and candidate reflect on confidence, independence and recognition
With
Associate Professor Kara Vine-Perrow,
Deputy Director Community Partnerships and Impact,
Molecular Horizons Research Institute UOW &
Group Leader, Targeted Cancer Therapeutics Research Laboratory
University of Wollongong
Dr Elahe Minaei,
Associate Research Fellow
University of Wollongong
SEGMENT
Filmed in Wollongong, NSW | September 2026
Pancreatic cancer remains one of the deadliest cancers, with survival rates below 10 per cent and treatments often as harsh as the disease itself.
Finding better ways to treat one of the deadliest cancers has become the focus of a University of Wollongong research team, where the relationship between a PhD supervisor and candidate has also played an important role in shaping the next generation of researchers.
Associate Professor Kara Vine-Perrow, Deputy Director of Community Partnerships and Impact at the Molecular Horizons Institute and Group Leader of the Targeted Cancer Therapeutics Lab at UOW, leads research into improving the delivery of drugs directly to diseased tissue. Her team is particularly focused on diseases with high unmet medical needs, including inoperable pancreatic cancer.
Whilst being a PhD candidate, Dr Minaei and her team developed biodegradable micro-implants that deliver chemotherapy and immunotherapy directly into tumours, targeting treatment at the source. This innovation reduces toxic side effects, activates the immune system, and makes powerful therapies safer and more effective.
Her preclinical studies show promising results, with industry partners calling the approach a “game changer” and clinicians hopeful it could finally make immunotherapy effective for pancreatic cancer.
For Dr Elahe Minaei, a recent PhD graduate and Associate Research Fellow in Vine-Perrow’s laboratory, the pancreatic cancer and immunotherapy project aligned closely with her background and research interests. Her previous experience in immunology and cancer cell and molecular biology helped shape her decision to undertake her PhD with Vine-Perrow.
The pair discussed their experience in a PhD Supervisor and PhD Candidate interview with Australian Health Journal, highlighting the importance of mentorship alongside scientific research.
“I think it’s very important that you know your supervisor,” Minaei said, emphasising the role of a supervisor in supporting both personal and professional growth.
Vine-Perrow said the progression of a PhD candidate towards independence was among the most rewarding aspects of supervision, particularly as the relationship ultimately develops into one between colleagues.
Source: Adapted from Shaping Australia Awards (Universities Australia) website and University of Wollongong media release (February 2026)
-
Practising to top scope of urology practice, advancing treatment & patient care through research
Michael is a urology nurse practitioner with a special interest in prostate cancer survivorship, and has worked in urology for the past ten years. Michael has completed the Prostate Nursing Care course at Latrobe University, Graduate Certificate of Health with a specialisation in Scheduled Medicines (USQ), and the Master of Nursing (Flinders) to become a Nurse Practitioner in 2024.
As a Urology Nurse Practitioner he divides his time between the Australian Prostate Centre and Western Urology.
-
The Case for Embedded Pharmacy in Residential Aged Care
Embedded pharmacy in residential aged care has been successful in South Australia at the Tanunda Lutheran Home in the Barossa Valley. Julian Soriano talks about his pharmacy role in medication management and medication safety to deliver the best clinical care for residents.
In this segment, Julian talks about the traditional pharmacy model serving residential aged care and the limitations of the imprest process for dispensing medication. Soon into the project he saw the collaboration required with GPs and onsite nurses in dispensing medication for residents in end-of-life or palliative care. Julian sees the imprest process unable to support end-of-life residents, even being able to check the availability of medication.
But what most may not be aware of, is his rapid growth since starting the business in 2013 having just been in health care a few years earlier. Being part of a 2nd generation health care family, Shawn learnt from his father on site and at trade show visits overseas. Prior to HPA, he spent 2 years working in fit-outs of operating theatres, neo-natal and general population ICU, throughout being more fascinated with what he saw. -
The world of AI avatars in dementia care
Dementia care is one of the critical issues facing the aged care industry. About 500,000 Australians currently live with the brain disorder condition, and this is tipped to rise to 1.1 million in a generation.
How to effectively provide quality care for people living with dementia was a key element of the royal commission into aged care, which found the complex care required was an ongoing challenge for the industry.
